Ed Wirth

Ed Wirth has a substantial work experience in the medical and biotechnology field. Ed currently serves as the Chief Medical Officer at Aspen Neuroscience since January 2020. Prior to that, they held the same position at Lineage Cell Therapeutics from March 2019 to December 2019. Ed also served as the Chief Medical Officer at Asterias Biotherapeutics from July 2015 to March 2019. Before that, they worked as the Chief Translational Officer at Asterias Biotherapeutics from March 2013 to July 2015.

In addition, Ed has worked as an Independent Consultant from October 2012 to March 2013. Ed served as the Chief Science Officer at InVivo Therapeutics Corporation from December 2011 to September 2012. Prior to that, they worked as the Medical Director at Geron Corporation from August 2004 to October 2011.

Ed's earlier work experience includes roles as a Research Associate at the University of Chicago Medical Center and as an Assistant Professor at Rush University Medical Center. Ed also worked as an Assistant Professor at the University of Florida from 1994 to 2001.

Ed Wirth attended Rollins College from 1982 to 1986, where they obtained a Bachelor of Arts (B.A.) degree in Physics. Ed then pursued further education at the University of Florida from 1986 to 1994, earning both a MD and PhD. No specific degree or field of study is mentioned for their time at the University of Florida.